Newfin Pharmaceuticals Private Limited
About Newfin Pharmaceuticals Private Limited
Data last updated:
Newfin Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 17 January 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1996PTC022898. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Suresh Adapa and Tamma Sandhya Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6 – 3 Sterling Emerald Plot No.118 Bhagyanagar Colony, Hyderabad, Telangana, India.
As per the financials filed for FY 2017, the company reported a revenue of ₹23.99 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹92,441 (net margin -3.9%) and EBITDA of -₹89,373 (EBITDA margin -3.7%).
As per MCA filings, the company has open charges of ₹30 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Newfin Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP1996PTC022898. The current CIN is U24239TG1996PTC022898, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1996PTC022898 | Current |
| U24239AP1996PTC022898 | Previous |
Contact details
Newfin Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered Address6 – 3 Sterling Emerald Plot No.118 Bhagyanagar Colony, Hyderabad, Telangana, India
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Newfin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Newfin Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Newfin Pharmaceuticals Private Limited, buy the company report.
Financials of Newfin Pharmaceuticals Private Limited
FY 2025 filings availableNewfin Pharmaceuticals Private Limited reported revenue of ₹23.99 Lakh (down 25% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue fell 25% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹23.99 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹89,373 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹92,441 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -3.7% | ||
| Net Profit Margin | -3.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Newfin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Newfin Pharmaceuticals Private Limited
Newfin Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Adapa Also directs: Aushadi Health Care Private Limited | Additional Director | 25 Aug 2015 | 11 Years 2 Months | Current |
| Tamma Sandhya Rani | Additional Director | 01 Jul 2016 | 10 Years 4 Months | Current |
Auditor
Newfin Pharmaceuticals Private Limited is audited by THIRUPALU REDDY M for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THIRUPALU REDDY M | FY 2017 | 203098 |
Shareholding
The shareholding of Newfin Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Newfin Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jul 2003 | 90117840 | Sbi | ₹10 Lakh | Open | |
| 02 Dec 1996 | 90117177 | Sbi | ₹20 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Newfin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Newfin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Newfin Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Newfin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Newfin Pharmaceuticals Private Limited has 8 board changes on record since 2009: 2 appointments and 6 cessations. The latest: Tamma Sandhya Rani was appointed as Additional Director on 01 Jul 2016.
1 earlier event is in the company report.
Frequently asked questions
Newfin Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical products, within the chemicals industry. It was incorporated on 17 January 1996 (30+ years old) and is registered under CIN U24239TG1996PTC022898.
Newfin Pharmaceuticals has 2 current directors:
- Suresh Adapa - Additional Director
- Tamma Sandhya Rani - Additional Director
The latest financial statements of Newfin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Newfin Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Newfin Pharmaceuticals is U24239TG1996PTC022898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Newfin Pharmaceuticals was incorporated on 17 January 1996, making it 30+ years old. It is registered with the Registrar of Companies, Hyderabad.
Tamma Sandhya Rani was appointed as Additional Director on 01 Jul 2016. Bonthu Venkata Reddy ceased to be Managing Director on 03 Nov 2015. Suresh Adapa was appointed as Additional Director on 25 Aug 2015. Newfin Pharmaceuticals has 8 board changes on record in total.
The registered office of Newfin Pharmaceuticals is at 6 – 3 Sterling Emerald Plot No.118 Bhagyanagar Colony, Hyderabad, Telangana, India.
Newfin Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
Newfin Pharmaceuticals has open charges of ₹30 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
